Diagnostic Value of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Patients with Severe COVID-19 - 7 PLADs, China, January 21-February 10, 2020
Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022..
What is already known about this topic?: Coronavirus disease 2019 (COVID-19) causes symptoms ranging from mild to severe. Indicators for identifying severe COVID-19 infection have not been well identified, especially for young patients.
What is added by this report?: Both neutrophil-lymphocyte ratio (NLR) [area under curve (AUC): 0.80; the odds ratios (OR) and 95% confidence intervals (95% CI): 1.30 (1.13-1.50)] and platelet-lymphocyte ratio (PLR) [AUC: 0.87; OR (95% CI): 1.05 (1.01-1.09)] were determined to be indicators for recognition of patients with severe COVID-19 in young patients less than age 40.
What are the implications for public health practice?: NLR and PLR are useful indicators for identifying patients with severe COVID-19, especially in young patients less than age 40.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
China CDC weekly - 4(2022), 10 vom: 11. März, Seite 195-198 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ma, Yan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 01.04.2022 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.46234/ccdcw2022.047 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM338866663 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM338866663 | ||
| 003 | DE-627 | ||
| 005 | 20231226001631.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.46234/ccdcw2022.047 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1129.xml |
| 035 | |a (DE-627)NLM338866663 | ||
| 035 | |a (NLM)35356643 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ma, Yan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Diagnostic Value of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Patients with Severe COVID-19 - 7 PLADs, China, January 21-February 10, 2020 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.04.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022. | ||
| 520 | |a What is already known about this topic?: Coronavirus disease 2019 (COVID-19) causes symptoms ranging from mild to severe. Indicators for identifying severe COVID-19 infection have not been well identified, especially for young patients | ||
| 520 | |a What is added by this report?: Both neutrophil-lymphocyte ratio (NLR) [area under curve (AUC): 0.80; the odds ratios (OR) and 95% confidence intervals (95% CI): 1.30 (1.13-1.50)] and platelet-lymphocyte ratio (PLR) [AUC: 0.87; OR (95% CI): 1.05 (1.01-1.09)] were determined to be indicators for recognition of patients with severe COVID-19 in young patients less than age 40 | ||
| 520 | |a What are the implications for public health practice?: NLR and PLR are useful indicators for identifying patients with severe COVID-19, especially in young patients less than age 40 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Neutrophil-lymphocyte ratio | |
| 650 | 4 | |a Severe Patient | |
| 650 | 4 | |a platelet-lymphocyte ratio | |
| 700 | 1 | |a Zhu, Dongshan |e verfasserin |4 aut | |
| 700 | 1 | |a Shi, Nannan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Lei |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Guangkun |e verfasserin |4 aut | |
| 700 | 1 | |a Ge, Youwen |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Zelei |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Renbo |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Sihong |e verfasserin |4 aut | |
| 700 | 1 | |a Fan, Yipin |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Huamin |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yanping |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t China CDC weekly |d 2019 |g 4(2022), 10 vom: 11. März, Seite 195-198 |w (DE-627)NLM313499349 |x 2096-7071 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2022 |g number:10 |g day:11 |g month:03 |g pages:195-198 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.46234/ccdcw2022.047 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2022 |e 10 |b 11 |c 03 |h 195-198 | ||